drugset / Trial / NCT00006131

Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster

NCT00006131

RandomizedDouble-blindTreatment

Summary

OBJECTIVES: I. Compare the efficacy and safety of two doses of oral valacyclovir in immunocompromised patients with uncomplicated herpes zoster. II. Compare quality of life, pain, and medical resource utilization in patients treated with these 2 regimens.

Timeline

Start
1997-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Valacyclovir Unknown Oral